The global Biological and Chemical Indicators Market is estimated to be valued at USD 549.8 million in 2025 and is projected to reach USD 904.2 million by 2035, registering a compound annual growth rate (CAGR) of 5.1% over the forecast period. The Biological & Chemical Indicators Market is experiencing sustained growth driven by heightened awareness of infection control and strict regulatory mandates in healthcare sterilization.
Increased procedural volumes in hospitals, outpatient settings, and dental clinics are expected to continue fueling demand for accurate, real-time sterilization validation. The ongoing shift toward single-use surgical equipment and growing concerns about cross-contamination have led to a wider adoption of both biological indicators (BIs) and chemical indicators (CIs). Additionally, rising investments in healthcare infrastructure in emerging economies are creating favourable conditions for market expansion.
Key manufacturers dominating the Biological & Chemical Indicators Market include 3M, Getinge Group, Steris plc, Mesa Labs, Cantel Medical (Sotera Health), Terragene, and Propper Manufacturing. These companies are actively enhancing sterilization assurance portfolios through product innovation, digital integration, and strategic acquisitions.
In 2025, Advanced Sterilization Products, Inc received received a regulatory nod from USAFDA for the sale of STERRAD™ SEALSURE™ Chemical Indicator and STERRAD VELOCITY™ Biological Indicator. Key players are focusing on digital integration, rapid-readout technologies, and geographic expansion to gain market share.
Strategic acquisitions, product innovation in smart indicators, and partnerships with hospitals and CSSDs are being prioritized to enhance workflow automation, ensure compliance, and strengthen brand presence across both high-growth emerging and regulated markets.
North America dominates the Biological & Chemical Indicators Market in 2025 due to its mature healthcare infrastructure, stringent sterilization guidelines from agencies such as the CDC and AAMI, and wide-scale hospital accreditation systems. High surgical throughput and centralization of sterilization departments have increased reliance on rapid-readout BIs and multi-parameter CIs.
Additionally, integration of sterilization tracking software with hospital information systems has become a standard, propelling demand for digitally enabled indicators. In Europe, market growth is being driven by evolving EN ISO standards, regional procurement mandates favoring traceable sterilization tools, and investments in public hospital upgrades.
Germany, France, and the UK are actively deploying digital sterilization assurance tools to align with sustainability and safety goals. The European trend toward automated sterile processing combined with training programs for infection control is enhancing adoption.
In 2025, biological indicators are expected to hold 85.6% of the revenue share in the biological and chemical indicators market. This dominance is primarily driven by the high accuracy and reliability of biological indicators in sterilization validation processes. Biological indicators are considered the gold standard for confirming the effectiveness of sterilization methods such as autoclaving, dry heat, and radiation.
Their widespread use in healthcare, pharmaceuticals, and food industries is due to their ability to provide direct evidence of the sterilization process by using living microorganisms. The growing demand for stringent sterilization standards, especially in sectors where contamination risk must be minimized (such as in medical device manufacturing and pharmaceuticals), has propelled the growth of this segment.
Furthermore, advancements in biological indicator technology, such as faster results and enhanced stability, have further increased their adoption. As industries continue to prioritize patient safety and regulatory compliance, the biological indicator segment is expected to maintain its leading market position.
In 2025, the biopharmaceutical industry is projected to capture 46.1% of the revenue share in the biological and chemical indicators market. This leadership position is driven by the critical role of sterilization processes in the biopharmaceutical sector, where product quality and patient safety are paramount. Biopharmaceutical manufacturers rely heavily on biological and chemical indicators to ensure that their products are free from microbial contamination, which is particularly crucial for injectable drugs, vaccines, and biologics.
Stringent regulatory requirements, such as those set by the FDA and EMA, have increased the demand for these indicators to verify sterilization efficacy during the manufacturing process. Additionally, the rise in biologics production and the growing complexity of biopharmaceuticals have led to more rigorous sterilization procedures and, consequently, a higher reliance on effective monitoring and validation tools. As the biopharmaceutical industry continues to expand, driven by innovations in personalized medicine and biologic drug development, the demand for biological and chemical indicators in this sector is expected to remain strong.
Challenges
Regulatory Compliance and Standardization Issues
The standardized regulatory requirements for sterilization monitoring in healthcare, pharmaceutical, and food industries will hinder the growth of the Biological &Chemical Indicator Market. These make manufacturers comply with;1) standardization issues in the performance of the indicators, 2) reliability considerations and 3) the need for frequent validation of sterilization processes that add further compliance burden on manufacturers. Furthermore, developing regions lack awareness, while advanced indicators come with high costs.
Opportunity
Growth in Healthcare Sterilization and Advanced Smart Indicators
This increasing demand for infection control and sterilization validation drives the aspects of the biological and chemical indicators in turn. The latest developments in smart sterilization monitoring solutions, such as real-time digital indicators, RFID-enabled tracking solutions and color-changing chemical indicators are enhancing process motivation accuracy and regulatory compliance. Moreover, growing applications in food safety, water purification, and industrial sterilization provide new growth opportunities.
The USA biological & chemical indicator market in the United States is expanding due to stringent sterilization regulations in the healthcare industry and increased requirements for infection control. Growing number of surgical procedures along with the increasing pharmaceutical and biotechnology industries is driving the demand of biological and chemical indicator for sterilization validation.
Furthermore, the presence of large medical device companies and regulatory bodies, including the FDA, which impose stringent sterilization and quality monitoring guidelines is also propelling the growth of the market. Moreover, the rising demand for new sterilization technologies in hospitals, pharmaceutical production, and food safety is propelling demand.
The increasing trend of contract sterilization services and laboratory testing facilities in the USA is also aiding the biological & chemical indicator market growth in the country.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 5.4% |
The biocide & chemical indicator segment will have a high growth rate during the forecast period and the increasing adoption of sterilization monitoring technologies in hospitals and laboratories. The need to adhere to strict sterilization protocols in the National Health Service (NHS) has led to enhanced demand for biological and chemical indicators in healthcare sectors.
As adiabatic these better investments are expected in the USA and global gene therapy, the UK is treated to the UK-isocal market size, while the pharmaceutical and biotechnology sectors are poised for growth. Furthermore, the growing number of surgical procedures and medical device manufacturing activity is also expected to boost demand for sterilization monitoring solutions.
Growing awareness regarding contamination risks associated with food and beverage industries is also driving the adoption of chemical and biological indicators for sterilization validation.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 4.9% |
The demand for the European Union (EU) biological & chemical indicator market is anticipated to witness upward growth, attributed to stern sterilization guidelines, growing healthcare costs, and continuous quality assurance in pharmaceutical and medical device manufacturing. With the implementation of MDR and GMP, the industries are compelled to use biological and chemical indicators extensively.
Germany, France, and Italy are major contributors to the market growth as they possess well-established healthcare infrastructure and pharmaceutical production facilities. Rising demands for sterilization validation in food processing and research laboratories further propel adoption.
Increasing prevalence of healthcare-associated infections (HAIs) are propelling hospitals and clinics to invest in improved sterilization monitoring solutions.
| Country | CAGR (2025 to 2035) |
|---|---|
| EU | 4.8% |
Japan has an advanced healthcare system and stringent sterilization protocols, which are driving steady growth of the biological and chemical indicator market in the country. An increasing number of medical procedures and rising demand for high-precision sterilization method in the pharmaceutical manufacturing is likely to propel the market growth.
Innovations in sterilization monitoring solutions are fueled by the nation’s leadership in ground-breaking medical device production and biotechnology research. Furthermore, stringent government regulations related to infection control and sterilization compliance in the healthcare settings are also driving the market.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 5.2% |
The biological & chemical indicators market in South Korea is growing due to rising demand for sterilization validation solutions in hospitals, laboratories, and pharmaceutical industry. Belarus has a vigorous biotechnology industry and burgeoning medical tourism, fueling increased demand for biological and chemical indicators.
Government regulations mandating sterilization checks in medical and dental clinics are also aiding the market expansion. Moreover, the future growth of the market is also known by the innovations of smart healthcare technologies in South Korea, such as the digital sterilization monitoring system.
Also, the increasing emphasis on contamination prevention in food processing and research applications is also shaping the demand for biological and chemical indicators.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 5.0% |
The biological and chemical indicators market features a mix of global leaders and specialized manufacturers across multiple tiers. Tier 1 companies like 3M Company, Steris Plc., and Thermo Fisher Scientific, Inc. lead with broad product portfolios, global reach, and strong innovation focus. 3M develops rapid sterilization indicators known for accuracy and ease of use, primarily serving healthcare and pharmaceutical sectors.
Steris Plc. offers integrated sterilization and infection prevention solutions, investing heavily in R&D for next-generation indicators. Thermo Fisher Scientific combines advanced biological indicators with digital monitoring to improve sterilization validation.
Tier 2 players such as Mesa Labs, Inc., McKesson Medical-Surgical Inc., and Crosstex International, Inc. focus on cost-effective, compliant indicators for hospitals and clinics, expanding regionally while enhancing customer service. Mesa Labs is known for precision in biological indicator manufacturing and validation, while McKesson leverages a broad healthcare distribution network.
Tier 3 suppliers, including Propper Manufacturing Co., Terragene S.A., Andersen Products, and Getinge AB, target niche markets and specialty users. Getinge integrates sterilization indicators into its advanced sterilization systems to boost process reliability.
Recent Biological & Chemical Indicators Industry News
In April 2025, 3M launched the 3M™ Attest™ Super Rapid Vaporized Hydrogen Peroxide Biological Indicator 1295, which delivers results in just 24 minutes. This rapid-readout system is designed to monitor vaporized hydrogen peroxide (VH₂O₂) sterilization processes, providing fast and accurate results to ensure the effectiveness of sterilization cycles.
The system complies with ISO 11138-1:2017 standards and is compatible with various sterilization systems, including STERRAD® and V-PRO® sterilizers. According to information available on 3M’s official website, this advancement enhances operational efficiency in healthcare facilities by enabling quicker release of sterilized equipment.
The overall market size for biological & chemical indicator market was USD 549.8 million in 2025.
The biological & chemical indicator market is expected to reach USD 904.2 million in 2035.
The growth of the biological & chemical indicator market will be driven by increasing demand for sterilization monitoring in healthcare, advancements in infection control technologies, and rising regulatory compliance requirements for medical device and pharmaceutical industries.
The top 5 countries which drives the development of biological & chemical indicator market are USA, European Union, Japan, South Korea and UK.
Chemical sterilization and biological indicators to command significant share over the assessment period.
Explore Life Science & Biotechnology Insights
Biological & Chemical Indicators Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
